This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In adults with congenital heart disease (ACHD patients), atrial arrhythmias (AA) and heartfailure (HF) are common. 1 Factors related to congenital heart disease, such as underlying anatomy, surgical repair technique and scars, can all be considered as AA substrates.
There is an unmet need to create consensus documents on the management of cardiorenal patients since, due to the aging of the population and the rise of both pathologies, these patients are becoming more prevalent in daily clinical practice. Chronic kidney disease coexists in up to 40%–50% of patients with chronic heartfailure cases.
Background Atrial arrhythmias (AA) and heartfailure (HF) are major causes of hospitalisation in adult congenital heart disease (ACHD). Dates of first AA and HF presentations were documented, and outcomes of RFA, including acute and long-term success, were assessed.
IntroductionVentricular assist devices (VADs) are lifesavers for people with advanced heartfailure. The top contributing authors in terms of total documents were Nose Y (35) and Throckmorton A (30) and in terms of total citations were Pagani F (2005) and Mehra M (1952).
Abstract In patients with heartfailure, neurohumoral activation leads to increased renal sodium avidity across the entire renal tubules, resulting in a positive sodium and water balance, leading to decompensated heartfailure requiring intravenous diuretics.
The maternal complications included pre-eclampsia (one patient), placental detachment (one patient), acute heartfailure exacerbation (one patient), arrhythmia (three atrial arrhythmias) and major peripartum haemorrhage (two patients), with no peripartum death.
Implantable devices form an integral part of the management of patients with heartfailure (HF) and provide adjunctive therapies in addition to cornerstone drug treatment. Although the number of these devices is growing, only few are supported by robust evidence. As such, device therapy should be integrated into HF care programmes.
In this episode, Andrea Price, MS, AACC hosts Jessie Dunne, PharmD, BCCP, BCPC and Orly Vardeny, PharmD, MS, FAHA, FHFSA to discuss the most recent heartfailure guidelines, expert consensus publication, and what these documents mean to a pharmacist working on a heartfailure care team.
Objectives (1) Develop a programme theory of why, for whom and in what contexts integrated palliative care (PC) and heartfailure (HF) services work/do not work; (2) use the programme theory to co-produce with stakeholders, intervention strategies to inform best practice and future research.
Therefore, the aim of this document is to summarize practical approaches to the treatment of cardiomyopathies, which includes the evidence-based novel therapeutic concepts and established principles of care, tailored to the individual patient aetiology and clinical presentation of the cardiomyopathy.
21, 2024 — The incidence rate of heartfailure was 2- to 3-fold higher among American Indian populations than rates observed in studies focused on other population groups, such as African American, Hispanic or white adults, in a new study published in the Journal of the American Heart Association.
Abstract Document Reviewers: Rudolf A. These have been compiled in a report and simultaneously published in a supplementary document to the Focused Update. The report is also available on the ESC website www.escardio.org/guidelines See the European Heart Journal online for supplementary documents that include evidence tables.
A newly released ACC Expert Consensus Decision Pathway (ECDP) focused on the clinical assessment, management and trajectory of patients hospitalized with heartfailure (HF) includes revisions to the 2019 version of the document and harmonizes guidance in response to the ACC/AHA HeartFailure Guideline released in 2022.
This electrode is stimulated by self-generated electricity from external ultrasonic waves transmitted from the surface of the heart through an ultrasonic generator. This weeks JAMA has reported an encouraging results with this device.The study documented reduction in end systolic volume by 16% and the ejection fraction as well.
The following are key points to remember from a 2024 ACC Expert Consensus Decision Pathway for treatment of heartfailure with reduced ejection fraction (HFrEF), an update to the 2021 document.
Objective Heartfailure remains a key public health priority across the globe. The median age of people with heartfailure admitted to hospital in the UK is 81 years old. Previous published competency frameworks in heartfailure have focused on the value of doctors, nurses and pharmacists.
Predicting the anticipated benefit and selecting the optimal timing of catheter ablation of recurrent ventricular tachycardia (VT) in patients with severe heartfailure (HF) can be challenging.
Abstract Diagnosing heartfailure is often difficult due to the non-specific nature of symptoms, which can be caused by a range of medical conditions. Natriuretic peptides (NPs) have been recognized as important biomarkers for diagnosing heartfailure. Use of this acronym would enable the early diagnosis of heartfailure.
Current Role of Digoxin in HeartFailure as Per Guidelines and DIGIT-HF trial of Digitoxin Use of digoxin in heartfailure has come down markedly over the past decades due to concerns of toxicity and availability of more effective medications. Eur Heart J. Erratum in: Eur Heart J. Eur J Heart Fail.
In this week’s View, Dr. Eagle looks at the consequences of discontinuing long-term drug treatment in patients with heartfailure and reduced ejection fraction (HFrEF). He then explores the effect of race and sacubitril/valsartan use in HF patients documented in a pooled analysis of the PARADIGM-HF and PARAGON-HF trials.
Journal of the American Heart Association, Ahead of Print. BackgroundBoth diabetes and low magnesiumcontaining food intake may increase the risk of heartfailure (HF).
The ACC's newest Expert Consensus Decision Pathway (ECDP) released in early March provides an updated framework for the many decisions required in the management and treatment of patients with heartfailure with reduced ejection fraction (HFrEF).
Increasing severity of obesity is associated with multiple characteristics that may contribute to the development or worsening of heartfailure (HF) with preserved ejection fraction (HFpEF). Obesity was associated with more first and recurrent heartfailure events.
Zio LTCM SymptomRhythm Correlation (SRC) Study : Symptoms Alone Are Unreliable Less Than 20% Correlation: In most arrhythmia types, fewer than one in five patients in the analysis documented a symptom coinciding with an arrhythmic episode. 3 billion per year, 8 while heartfailure costs could reach $70 billion by 2030.
The project used Tableau to review the 30-day readmission rate.Results:Quality improvement measures were initiated at the community hospital in September 2023 to decrease the 30-day readmission rate.
When the valve narrows, it does not open or close properly, making the heart work harder to pump blood throughout the body. Eventually, this causes the heart to weaken and function poorly, which may lead to heartfailure and increased risk for sudden cardiac death. 5 Verbelen T, Roussel JC, Cathenis K, et al.,
The earlier indication of catheter ablation (CA) to atrial fibrillation (AF) had suggested the better outcome post-CA before advancement in left atrial remodeling. However, the optimal timing of CA in patients with a low burden of AF remains unknown.
When the valve narrows, it does not open or close properly, making the heart work harder to pump blood throughout the body. Eventually, this causes the heart to weaken and function poorly, which may lead to heartfailure and increased risk for sudden cardiac death. 5 Verbelen T, Roussel JC, Cathenis K, et al.,
The co-occurrence of keywords has generated 8 clusters, including DCM, lamin a/c, heartfailure, sudden cardiac death, hypertrophic cardiomyopathy, cardiac hypertrophy, arrhythmogenic cardiomyopathy, and next-generation sequencing.
The newly-published document, reported ESC in a written statement, sets out best practice standards and practical advice on which patients should receive ablation, how to perform the procedure, and how to manage patients before, during and afterwards. Document link: [link] If you enjoy this content, please share it with a colleague
Introduction:Given the well-documented benefits of yoga on the cardiovascular system and improvement of exercise tolerance and quality of life, the American Heart Association recently recommended yoga as a safe and well-tolerated adjunctive therapy for patients with heartfailure (HF).
While reduced systolic function and heartfailure (HF) symptoms have been widely described, there is still a lack of reports about the arrhythmic manifestations of the disease. Arrhythmias were documented in all the patients during the first cardiological assessment.
In heartfailure with reduced ejection fraction and heartfailure with preserved ejection fraction, profound cellular and molecular changes have recently been documented in the failing myocardium.These changes include altered calcium handling and metabolic efficiency of the cardiac myocyte, reactivation of the fetal gene program, changes in the electrophysiological (..)
ATTRwt was previously known as “senile amyloidosis” and causes cardiomyopathy which may lead to heartfailure with a preserved ejection fraction, affecting predominantly elderly men. ATTR may result from transthyretin mutations (variant ATTR or ATTRv) or may occur with normal transthyretin genotype (wild type ATTR or ATTRwt).
Circulation: HeartFailure, Ahead of Print. BACKGROUND:The long-term impact of bariatric surgery on cardiac mechanics and energetics has been scarcely documented.
Association between big ET-1 and prognosis of AL-CA has not yet been documented. The secondary outcomes included death from cardiac cause and the composite of the primary outcome or hospitalisations due to worsening heartfailure. Primary outcome was all-cause mortality. During a median follow-up time of 25.7
Therefore, the European Society of Cardiology (ESC) has developed a special core curriculum for cardio-oncology, a consensus document that defines the level of experience and knowledge required for cardiologists in this particular field.
His history included known heartfailure with prior EF 18%, insulin dependent diabetes, and polysubstance abuse. RED dotted lines in ECG #2 that mark the ST segment baseline in lead V2 , and leads V4 , V5 , V6 — document new ST elevation that was not present in ECG #1. Vitals were within normal limits except for tachypnea.
About AFib, AI and Clinical Trials from HRS 2024 The American Heart Association defines AFib as a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heartfailure, and other heart-related complications. 1 Approximately 33 million patients worldwide are living with AFib.
AF-CHF trial in those with AF and congestive heartfailure also failed to show any advantage for the rhythm control strategy [3]. Overall, it appears that rhythm control strategy in AF may be better in those with heartfailure and in those with associated cardiovascular conditions and early AF.
Fisher’s exact tests were used to investigate subgroup differences based on age, gender, race and heartfailure (HF) status. The most frequently documented symptoms were dyspnoea (64%), oedema (62%) and palpitations (57%). Results A total of 1293 patients were included in our analysis (mean age 65.5 female, 58% white).
Understanding ECG Machines Electrocardiogram machines are medical devices used to record the heart’s electrical activity. They are indispensable tools in diagnosing cardiac conditions such as arrhythmias, heart attacks, and heartfailure.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content